Computational investigation of a celecoxib-derived compound as a potential COX-2 inhibitor
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
The development of cyclooxygenase-2 (COX-2) inhibitors plays a key role in developing safer anti-inflammatory therapies. The study based on the examination of a celecoxib-derived compound (T1) to analyse its potential as a COX-2 inhibitor. Density functional theory (DFT) calculations were carried out to optimize the molecular geometry and evaluate the electronic structure parameters of the designed compound. HOMO and LUMO energies (Frontier molecular orbital) were extracted from the optimized output files. These were utilised to calculate global reactivity descriptors including, ionization energy, electron affinity and electronegativity. The potential energy scan showed the proton transfer reaction and the stability of keto form in the excited state. Molecular docking analysis showed that the designed ligand fits well within the hydrophobic channel of the COX-2 enzyme. The binding pocket is mainly surrounded by hydrophobic amino acid residues including, Phe381, Leu352, Val349, Val523, Ala527, Leu384 and Phe518. The molecular dynamics studies showed that the compound forms a stable complex with COX-2 during the 100 ns simulation. The protein maintains its structural stability and the ligand remains bound within the active site. Overall, the combined results supporting its potential as a selective COX-2 inhibitor and providing a foundation for future experimental validation that can help in the design of safer and more effective anti-inflammatory drugs.
Fields of Study & Subjects
Computational Drug Discovery Methods
Inflammatory mediators and NSAID effects
Heterocyclic Compound Synthesis and Bioactivity
Publication details
- Journal / source
- International Journal of Chemical Studies
- Volume
- 14
- Issue
- 3
- Pages
- 30–36
- Publication date
- 1 March 2026
- Language
- EN